Bryan Johnson graduated from the University of Illinois at Urbana-Champaign with a degree in computer science and mathematics and later went on to get his MBA from the University of Chicago Booth School of Business.
When he was 21, he had an aspiration to do something meaningful for humanity. This led him to study the works and biographies of hundreds and hundreds of people who had the vision to see the things on the horizon even when they were barely reachable for them in their lifetime.
Bryan Johnson started a bunch of start-ups, and he was struggling to pay the bills for his start-ups. He applied for more than 60 jobs, but everything was in vain. But, finally, he landed a credit card processing job with 100% commission on it, and he was selling door to door. He quickly rose to become the company’s top salesperson.This experience got him into the payment business.
He found a big opportunity in the payments niche and founded Braintree. The first real break came from the OpenTable deal to build a custom solution for them to save their customers’ critical data. Slowly, he expanded his reach and added customers like Airbnb, GitHub, and Uber. Bryan Johnson sold Braintree to PayPal for over $800 million, and he was 34 years old at the time. His estimated total wealth is $420 million.
What is Kernal and How Bryan Johnson Spends His Money :
Bryan Johnson has invested $100 million in the company to unlock the power of the human brain. The company is developing a neuroprosthesis that can be implanted in people’s brains to help them with memory and cognitive tasks.
The company has been developing a neural lace that can be injected into people’s brains and help them with their mental health. The lace will be able to monitor brain activity and send signals back to adjust the brain. This could be used to treat depression, anxiety, ADHD, and other mental illnesses.
Bryan Johnson’s Blueprint:
Project Blueprint is a new endeavor that aims to measure all 70+ organs of my body and then maximally reverse the quantified biolog.
Dr. David K. Mills is a scientist and inventor who has been working on this project for over 20 years, focusing mostly on reversing the aging process in mice. His newest goal is to do it for humans as well. He has had some promising results from his most recent tests and believes it’s just a matter of time before the technology can be used for humans as well.
